Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Oral
-
-
CompaniesPfizerPharma Science & Research
Pfizer Abandons Ionis’ Cardiovascular and High Triglyceride Program
by adminby adminSummary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
-
AgrochemicalsCovid Drugs
Merck’s COVID-19 pill active against Omicron in lab studies
by adminby adminSummary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
-
Agrochemicals
PF-07321332 & Ritonavir (Paxlovid): Pfizer Gets CDSCO Panel Nod To Study For COVID Treatment
by adminby adminPF-07321332 & Ritonavir (Paxlovid): Pfizer Gets CDSCO Panel Nod To Study For COVID Treatment. The Central Drugs Standard Control Organisation(CDSCO) under Directorate General…
-
Agrochemicals
Pharmaceutical companies allowed royalty-free licenses for covid-19 treatment.
by adminby adminHIGHLIGHTS: Spain’s top research institution struck a licensing deal that paves the way for its COVID-19 antibody test to be produced more…
-
CompaniesPfizerTofacitinib
Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
by adminby adminAbstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…
-
Diroximel Fumarate
The European Commission Grants Marketing Authorization for VUMERITY® (Diroximel Fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis.
by adminby adminSYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…
-
Active Pharmaceutical Ingredients (API)PAXLOVID
Pfizer prepares to Launch COVID-19 Oral Antiviral Pill Reduced Risk of Hospitalization or Death by 89% in Interim Analysis.
by adminby adminKEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…
-
Agrochemicals
The United Kingdom becomes the First Country to Approve Molnupiravir Merck`s Oral Antiviral Drug
by adminby adminKEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…
-
Agrochemicals
An Exciting Strategic Collaboration between Dunad Therapeutics and Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies.
by adminby adminKEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a strategic…
Newer Posts